Trevi Therapeutics, Inc. (TRVI)

NASDAQ: TRVI · Real-Time Price · USD

11.21

-0.50 (-4.27%)

At close: Jan 8, 2026, 4:00 PM EST

11.35

+0.14 (1.25%)

After-hours: Jan 8, 2026, 6:27 PM EST

Trevi Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2019
Period Ending	Jan '26 Jan 8, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2019
Market Capitalization	1,437	368	86	116	20	44	Upgrade
Market Cap Growth	287.59%	330.28%	-26.01%	472.04%	-54.55%	-33.49%	Upgrade
Enterprise Value	1,220	304	-2	1	6	5	Upgrade
Last Close Price	11.71	4.12	1.34	1.93	0.78	2.42	Upgrade
PB Ratio	7.91	3.70	1.04	1.08	1.18	1.63	Upgrade
P/TBV Ratio	7.45	3.70	1.04	1.08	1.18	1.63	Upgrade
Debt / Equity Ratio	0.00	0.01	0.02	0.09	0.86	0.52	Upgrade
Quick Ratio	21.69	10.29	14.33	8.99	2.90	8.10	Upgrade
Current Ratio	21.93	10.41	15.03	9.15	2.98	8.33	Upgrade
Return on Equity (ROE)	-36.87%	-52.59%	-30.59%	-46.82%	-153.03%	-80.07%	Upgrade
Return on Assets (ROA)	-23.93%	-32.15%	-19.96%	-23.15%	-47.42%	-37.91%	Upgrade
Return on Capital (ROIC)	-25.61%	-34.90%	-21.15%	-25.18%	-55.37%	-42.13%	Upgrade
Return on Capital Employed (ROCE)	-27.00%	-51.30%	-40.60%	-27.30%	-126.10%	-78.10%	Upgrade
Earnings Yield	-3.24%	-13.01%	-33.97%	-25.21%	-167.88%	-73.64%	Upgrade
FCF Yield	-3.11%	-10.40%	-37.22%	-24.50%	-143.18%	-65.27%	Upgrade
Buyback Yield / Dilution	-24.43%	-2.97%	-53.44%	-182.56%	-26.48%	-53.88%	Upgrade

Updated Nov 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q